You have 9 free searches left this month | for more free features.

Secondary Sjogren

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Sjogren Syndrome, Secondary Sjogren Syndrome, Aqueous Deficient Dry Eye Disease Trial in Sao Paulo (Restasis, Refresh

Completed
  • Primary Sjogren Syndrome
  • +3 more
  • Sao Paulo, SP, Brazil
    Departamento de Oftalmologia da Escola Paulista de Medicina - UN
Sep 20, 2020

The Pathogenesis and Natural History of Sjogren s Syndrome

Recruiting
  • Pathogenesis
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    Dry Eye, Sjogren Syndrome Trial in Cairo (Cyclosporins, Tacrolimus)

    Completed
    • Dry Eye
    • Sjogren Syndrome
    • Cairo, Egypt
      Pavly Moawad
    May 20, 2019

    Sjogren-Larsson Syndrome Trial in Omaha (ADX-629)

    Recruiting
    • Sjogren-Larsson Syndrome
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Nov 7, 2022

    Medico-economic and Quality of Life Impact of Sjogren-associated

    Recruiting
    • Primary Sjögren Syndrome
    • +3 more
    • Collection sheet
    • Paris, France
      Département de Médecine Interne - Hôpital Lariboisière
    Aug 27, 2021

    SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)

    Recruiting
    • SLE (Systemic Lupus)
    • +4 more
    • CD19 targeted CAR-T cells
    • Taiyuan, Shanxi, China
      Shanxi Bethune Hospital
    Sep 25, 2023

    Sjogren's Syndrome Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (tofacitinib, Placebo)

    Recruiting
    • Sjogren's Syndrome
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 24, 2022

    Sjogrens Syndrome Trial (Ianalumab (VAY736), Placebo)

    Not yet recruiting
    • Sjogrens Syndrome
    • Ianalumab (VAY736)
    • Placebo
    • (no location specified)
    Aug 3, 2023

    Patterns, Real-world Effectiveness, and Healthcare Resource

    Not yet recruiting
    • Dry Eye Disease
    • (no location specified)
    May 10, 2023

    Sjögren Syndrome Trial in Worldwide (LOU064, Placebo)

    Terminated
    • Sjögren Syndrome
    • Boston, Massachusetts
    • +25 more
    Jan 27, 2023

    Sjogren's Syndrome, Xerostomia Trial (natural herbs of coconut, aloe vera, and pepperint, carboxy methyl cellulose)

    Not yet recruiting
    • Sjogren's Syndrome
    • Xerostomia
    • natural herbs of coconut, aloe vera, and pepperint
    • carboxy methyl cellulose
    • (no location specified)
    Aug 18, 2021

    Chronic Non-cancer Patients Treated With Opioids

    Active, not recruiting
    • Pain
    • +4 more
      • (no location specified)
      May 3, 2022

      Dry Eye Syndromes, Hypovitaminosis D Trial in Chakwal (Vitamin D, Artificial tear)

      Completed
      • Dry Eye Syndromes
      • Hypovitaminosis D
      • Vitamin D
      • Artificial tear
      • Chakwal, Punjab, Pakistan
        RHC Buchal Kalan
      Jun 15, 2022

      Systemic Sclerosis Trial in Brest, Rennes, Tours (Minor Salivary gland Biopsy, ARFI, MSG US)

      Completed
      • Systemic Sclerosis
      • Minor Salivary gland Biopsy
      • +2 more
      • Brest, France
      • +2 more
      Apr 4, 2022

      Polymyalgia Rheumatica Associated to Primary Sjogren Syndrome

      Recruiting
      • Polymyalgia Rheumatica
      • Sjogren's Syndrome
        • Brest, France
          CHRU Brest
        Mar 28, 2022

        Cytokine Storm Trial in Cairo (Non-Surgical periodontal therapy)

        Completed
        • Cytokine Storm
        • Non-Surgical periodontal therapy
        • Cairo, Egypt
          Faculty of Dentistry-Ain Shams University
        Sep 24, 2023

        Evaluation of Dental Coronal Restorations

        Completed
        • History of at Least One Coronal Dental Restoration
        • Evaluation of the quality of direct and indirect partial dental coronal restorations in adults
        • Bordeaux, France
        • +60 more
        Mar 16, 2022

        Pterygium Trial (OPHTESIC LIDOCAINE HYDROCHLORIDE 20MG/G, Xylocaine with Epinephrine)

        Not yet recruiting
        • Pterygium
        • OPHTESIC LIDOCAINE HYDROCHLORIDE 20MG/G
        • Xylocaine with Epinephrine
        • (no location specified)
        Jul 30, 2023

        Advanced Malignant Solid Tumor, Autoimmune Disease, Crohn Disease Trial in Canada, United States (Nivolumab)

        Recruiting
        • Advanced Malignant Solid Neoplasm
        • +15 more
        • Biospecimen Collection
        • Nivolumab
        • Birmingham, Alabama
        • +46 more
        Jan 31, 2023

        Primary Sjögren's Syndrome Trial in United States (Parsaclisib)

        Completed
        • Primary Sjögren's Syndrome
        • Miami, Florida
        • +3 more
        Aug 11, 2021

        Associated Burden of Related Conditions in Alopecia Areata

        Completed
        • Alopecia Areata
        • +35 more
        • Exposure of interest (studies 2 & 3).
        • London, United Kingdom
          Momentum Data Ltd
        Dec 13, 2022

        Systemic Lupus Erythematosus Trial in Sohag (Anti _KU antibodies)

        Recruiting
        • Systemic Lupus Erythematosus
        • Anti _KU antibodies
        • Sohag, Egypt
          Sohag University Hospitals
        Jun 8, 2023

        Primary Sjögren's Syndrome Trial in Berlin (VAY736, Placebo)

        Completed
        • Primary Sjögren's Syndrome
        • Berlin, Germany
          Novartis Investigative Site
        Sep 30, 2021

        Sjogren's Syndrome, Overactive Bladder Syndrome Trial in Taichung (mirabegron, oxybutynin, tolterodine, solifenacin)

        Recruiting
        • Sjogren's Syndrome
        • Overactive Bladder Syndrome
        • Taichung, Taiwan
          China Medical University Hospital
        Aug 8, 2021

        Obesity Trial in Turku (Weight vest, Wheelchair)

        Enrolling by invitation
        • Obesity
        • Weight vest
        • Wheelchair
        • Turku, Finland
          Turku University Hospital, Turku PET Centre
        Nov 1, 2022